Global High-Priority Regulatory Events — February 12, 2026

13-02-2026

13-02-2026

13-02-2026

13-02-2026

13-02-2026

13-02-2026

13-02-2026

13-02-2026

13-02-2026

13-02-2026

13-02-2026

13-02-2026

13-02-2026

13-02-2026

Synchronoss Technologies Inc filed an 8-K on 2026-02-13 disclosing the termination of a material definitive agreement (Item 1.02) and completion of an acquisition or disposition of assets (Item 2.01), alongside notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to rights of security holders (Item 3.03), changes in control of the registrant (Item 5.01), departures or elections of directors and officers (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), submission of matters to a vote of security holders (Item 5.07), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No quantitative financial metrics, deal values, parties involved, or specific transaction terms were disclosed. These events indicate major corporate restructuring with no offsetting positive metrics provided.

13-02-2026

AMC Entertainment Holdings, Inc. filed an 8-K on 2026-02-13 under Item 1.01 disclosing entry into a Material Definitive Agreement and under Item 9.01 providing Financial Statements and Exhibits. No specific details, transaction values, financial metrics, parties involved, or impacts are disclosed in the provided filing summary. No quantitative data or period-over-period comparisons are mentioned.

13-02-2026

Haymaker Acquisition Corp. 4 filed an SEC document on February 13, 2026 (AccNo: 0001104659-26-014575, size 13 MB) related to a Merger/Acquisition event. No specific details on deal structure, parties involved beyond the filer, valuation, consideration, strategic rationale, regulatory pathway, shareholder impact, or market implications are explicitly stated or disclosed in the provided metadata. Critical transaction terms, financial metrics, and quantitative data are entirely absent.

• ·Filing Accession Number: 0001104659-26-014575
• ·Filing Size: 13 MB
• ·Sector: not specified

13-02-2026

W. P. Carey Inc. filed a Form 8-K on 2026-02-13 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, events, transaction values, financial metrics, or impacts disclosed in the provided information. No positive or negative metrics are mentioned.

13-02-2026

Nektar Therapeutics filed a Form 8-K on 2026-02-13 reporting Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing focused on a material agreement and additional events, with exhibits attached. No financial metrics, transaction details, positive or negative impacts, or quantitative data are disclosed.

13-02-2026

ALLIANCE ENTERTAINMENT HOLDING CORP filed an 8-K on February 13, 2026 (AccNo: 0001493152-26-006492), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). Specific details on the officer change, including name, position, appointment or resignation status, reasons, and timing, are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or other numerical data are mentioned.

13-02-2026

SunHydrogen, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001213900-26-015747, Size: 380 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties, financial impacts, or other metrics are disclosed. This is a multi-item mandatory filing with no period-over-period comparisons or quantitative data provided.

13-02-2026

13-02-2026

13-02-2026

CERO Therapeutics Holdings, Inc. filed a Form 8-K on February 13, 2026, disclosing multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 3.02 (Unregistered Sales of Equity Securities), 4.01 (Changes in Registrant's Certifying Accountant), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), and 9.01 (Financial Statements and Exhibits). No specific transaction values, financial metrics, named parties, or quantitative impacts are disclosed in the provided filing summary. This multi-item filing signals several operational and financial changes, but lacks details to assess directional impact.

13-02-2026

Nova Iron & Steel Ltd. (BSE: 513566) has disclosed under SEBI LODR Regulation 30 that an application has been filed against the company under Section 7 of the IBC, 2016, indicating initiation by a financial creditor. The company received an email notice dated February 13, 2026. No details on default amount, creditor identity, company financials, or further proceedings are provided in the filing.

13-02-2026

Immunic, Inc. filed a Form 8-K on 2026-02-13 disclosing multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details, transaction values, personnel names, share counts, or financial metrics are disclosed in the provided filing summary. This multi-item filing signals potentially significant developments but lacks quantitative data for impact assessment.

13-02-2026

13-02-2026

13-02-2026

13-02-2026

Tri Pointe Homes, Inc. filed a Form 8-K on February 13, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific quantitative details, transaction sizes, financial impacts, or directional metrics disclosed. No positive or negative performance metrics are provided.

13-02-2026

13-02-2026

Noodles & Co filed a Form 8-K on February 13, 2026, under Item 3.03 disclosing material modifications to rights of security holders, Item 5.03 reporting amendments to articles of incorporation or bylaws or a change in fiscal year, Item 8.01 for other events, and Item 9.01 for financial statements and exhibits. This is a multi-item filing with no quantitative financial metrics, transaction details, or performance comparisons provided. No positive or negative impacts are quantified in the available information.

13-02-2026

Bloomin' Brands, Inc. filed an 8-K on 2026-02-13 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the officer's name, position, reason for change, or timing are disclosed.

13-02-2026

Sonic Automotive Inc filed an 8-K on February 13, 2026 (AccNo: 0001628280-26-007898) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative impacts are disclosed. This is a standard governance filing with no financial metrics, performance data, or scheduled events mentioned.

13-02-2026

LCI Industries filed an 8-K on February 13, 2026 (AccNo: 0000763744-26-000004, size 705 KB), disclosing an officer change under Item 5.02 covering departure of directors or certain officers, election or appointment of directors/officers, and compensatory arrangements of certain officers. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No specific details on affected positions, individuals, reasons for change, or financial metrics are disclosed.

• ·Event date: February 13, 2026
• ·Source: us_sec
• ·Sector: not specified

13-02-2026

Evommune, Inc. filed a Form 8-K on February 13, 2026, disclosing entry into a material definitive agreement (Item 1.01) and unregistered sales of equity securities (Item 3.02), alongside Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). While the material agreement signals potential strategic advancement, the equity sales raise dilution concerns. No specific transaction values, terms, financial impacts, or quantitative details are disclosed.

13-02-2026

13-02-2026

13-02-2026

LAS VEGAS SANDS CORP filed an 8-K on 2026-02-13 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided. Sector is not specified.

13-02-2026

GENCO SHIPPING & TRADING LTD filed an 8-K on 2026-02-13 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, names, reasons, or timing were disclosed.

13-02-2026

HCW Biologics Inc. filed an 8-K on February 13, 2026, disclosing entry into a Material Definitive Agreement under Item 1.01 and providing Financial Statements and Exhibits under Item 9.01. No details on the agreement's parties, terms, value, strategic rationale, or financial impacts are mentioned. This is a multi-item mandatory filing with no quantitative metrics, positive or negative changes, or performance comparisons provided.

13-02-2026

SAFE & GREEN HOLDINGS CORP. filed an 8-K on 2026-02-13 under Item 1.01 disclosing entry into a material definitive agreement and Item 9.01 for financial statements and exhibits. No details on the agreement's nature, parties, dollar value, strategic importance, or financial impacts are disclosed in the provided information. This is a multi-item mandatory filing likely made timely on the event date.

13-02-2026

Royal Caribbean Cruises Ltd filed an 8-K on February 13, 2026 (AccNo: 0001104659-26-014730), reporting under Item 1.01 entry into a material definitive agreement and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or metrics are disclosed. This appears to be a multi-item mandatory filing with limited public summary information available.

• ·Filing size: 482 KB
• ·Sector: not specified

13-02-2026

Citius Pharmaceuticals, Inc. filed a Form 8-K on February 13, 2026 (AccNo: 0001213900-26-015895), disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, and under Item 2.02 results of operations and financial condition. Item 9.01 references financial statements and exhibits. This multi-item filing highlights a material compliance failure with exchange listing requirements, with no specific financial metrics or performance details provided.

• ·Multi-item 8-K filing (Items 2.02, 3.01, 9.01)
• ·Event date aligns with filing date: 2026-02-13

13-02-2026

SOUTH DAKOTA SOYBEAN PROCESSORS LLC filed an 8-K on 2026-02-13 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any financial metrics are provided in the available information. No quantitative data, performance comparisons, or other outcomes are mentioned.

13-02-2026

Graco Inc filed a Form 8-K on February 13, 2026 (AccNo: 0000042888-26-000036, size 141 KB), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions (e.g., CEO, CFO), individuals involved, reasons for the change, effective dates, or any quantitative terms are explicitly stated. This represents a standard officer change event with sector not specified and no associated financial metrics or performance comparisons provided.

• ·AccNo: 0000042888-26-000036
• ·Event Type: Officer Change
• ·Source: us_sec

13-02-2026

Mag Magna Corp filed an 8-K on February 13, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the key position affected, individual names, appointment or resignation status, reasons, or timing are disclosed. Sector information is not specified.

13-02-2026

Columbus Circle Capital Corp II filed a Form 8-K on February 13, 2026, disclosing multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details, transaction values, personnel names, financial metrics, or quantitative impacts are disclosed in the provided filing summary. This multi-item filing signals several corporate developments but lacks data for directional assessment.

13-02-2026

Immersion Corp filed a Form 8-K on 2026-02-13 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, along with transfer of listing. The filing also includes Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No financial metrics, transaction values, or other quantitative details are disclosed.

13-02-2026

Olympic Steel Inc. filed an 8-K on February 13, 2026, reporting the termination of a material definitive agreement (Item 1.02) and the completion of an acquisition or disposition of assets (Item 2.01), alongside changes in control of the registrant (Item 5.01). The filing also discloses notice of delisting or failure to satisfy listing standards with transfer of listing (Item 3.01), material modifications to rights of security holders (Item 3.03), departure/election of directors and officers (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03). No quantitative financial metrics, deal values, parties involved, or performance comparisons were disclosed.

13-02-2026

POOL CORP filed an 8-K on February 13, 2026 (AccNo: 0001193125-26-051351), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including affected positions, names, reasons for the change, internal/external status, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material impacts are mentioned.

13-02-2026

FOX FACTORY HOLDING CORP filed an 8-K on February 13, 2026 (AccNo: 0001424929-26-000004), disclosing information under Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details on affected positions, individuals involved, reasons for change, or any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

13-02-2026

Marpai, Inc. filed an 8-K on 2026-02-13 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement). Item 9.01 includes Financial Statements and Exhibits. No quantitative details, transaction specifics, parties, dollar values, or impacts are disclosed.

13-02-2026

Tennant Co filed a Form 8-K on February 13, 2026, disclosing entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, along with Regulation FD disclosure under Item 7.01 and financial statements/exhibits under Item 9.01. This is a multi-item mandatory filing with no specific transaction details, dollar values, or financial metrics provided. No positive or negative quantitative impacts, guidance changes, or operational metrics were disclosed.

13-02-2026

BiomX Inc. filed an 8-K on 2026-02-13 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons, timing, or any quantitative metrics are disclosed. No positive or negative performance metrics are mentioned.

13-02-2026

Zenas BioPharma, Inc. filed an 8-K on 2026-02-13 disclosing officer changes under Item 5.02, including potential departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific names, positions, reasons for changes, financial metrics, or quantitative details are disclosed.

13-02-2026

LendingTree, Inc. filed an 8-K on February 13, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or timing are disclosed. No financial metrics, quantitative data, or other outcomes such as board decisions are mentioned.

13-02-2026

NEXTNRG, INC. filed an 8-K on February 13, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction terms, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This is a multi-item mandatory disclosure with no period-over-period comparisons or other numerical data available.

13-02-2026

Texas Roadhouse, Inc. filed a Form 8-K on 2026-02-13 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or impacts are disclosed. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.

13-02-2026

Bayview Acquisition Corp filed an 8-K on February 13, 2026, disclosing under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. No specific details such as amounts, terms, parties involved, or connection to any merger/acquisition are provided in the filing summary. Sector is not specified.

13-02-2026

Offerpad Solutions Inc. filed an 8-K on February 13, 2026 (AccNo: 0001193125-26-051334), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individuals involved, reasons for the change, or any quantitative impacts are disclosed.

13-02-2026

Spring Valley Acquisition Corp. IV filed an 8-K on 2026-02-13 disclosing entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, departure/election/appointment of directors/officers and compensatory arrangements under Item 5.02, amendments to articles of incorporation or bylaws or change in fiscal year under Item 5.03, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No quantitative deal terms, financial metrics, parties involved beyond the filer, or performance comparisons were disclosed. This filing signals a likely SPAC de-SPAC merger but lacks specifics for impact assessment.

13-02-2026

Ryerson Holding Corp filed an 8-K on February 13, 2026, disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also covers creation of a direct financial obligation (Item 2.03), departure or election of directors/officers or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific transaction parties, values, metrics, or impacts are disclosed.

13-02-2026

Newell Brands Inc. filed a Form 8-K on 2026-02-13 disclosing matters under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed.

13-02-2026

e.l.f. Beauty, Inc. filed an 8-K on 2026-02-13 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individuals involved, reason for change, or any financial impacts are provided. No quantitative metrics, performance data, or scheduled events mentioned.

13-02-2026

Healthcare Triangle, Inc. filed an 8-K on February 13, 2026, disclosing events under Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, financial metrics, transaction values, or directional impacts are provided in the filing summary. This appears to be a multi-item mandatory filing with no quantified positive or negative changes disclosed.

13-02-2026

Kestrel Group Ltd filed an 8-K on February 13, 2026 (AccNo: 0001628280-26-008071), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the affected position, individual names, appointment/resignation status, reasons, or impacts are disclosed.

13-02-2026

SpyGlass Pharma, Inc. filed an 8-K on February 13, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, appointment or resignation status, reasons for change, or any financial metrics are provided in the available information. No positive or negative impacts, quantitative data, or further context such as board composition changes are disclosed.

13-02-2026

Alphabet Inc. filed an 8-K on February 13, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other event, financial statements, exhibits, or any quantitative metrics are disclosed in the provided filing metadata. This appears to be a multi-item, likely voluntary disclosure with unknown materiality.

13-02-2026

Society Pass Incorporated filed an 8-K on February 13, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, events, transaction value, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This multi-item filing signals potentially significant developments, but lacks context for directional assessment.

13-02-2026

Intensity Therapeutics, Inc. filed a Form 8-K on February 13, 2026, reporting multiple items: Item 3.03 on material modifications to rights of security holders, Item 5.03 on amendments to articles of incorporation or bylaws or change in fiscal year, Item 8.01 on other events, and Item 9.01 on financial statements and exhibits. No specific details, transaction values, financial metrics, positive or negative changes, or numerical data are disclosed in the provided filing summary. This is a multi-item informational filing with no disclosed impacts on revenue, earnings, balance sheet, or guidance.

13-02-2026

Centessa Pharmaceuticals plc filed an 8-K on 2026-02-13 (AccNo: 0001193125-26-051424, Size: 189 KB) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key position affected (e.g., CEO, CFO), appointment or resignation status, reasons, timing, or any financial metrics are disclosed. No positive or negative governance implications can be assessed due to lack of details.

• ·AccNo: 0001193125-26-051424
• ·Filing size: 189 KB
• ·Sector: not specified

13-02-2026

PLUS Therapeutics, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001193125-26-051379) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on individuals, positions, reasons for change, or terms are disclosed. No quantitative metrics, financial impacts, or other changes are mentioned.

13-02-2026

Jet.AI Inc. filed a multi-item Form 8-K on February 13, 2026 (AccNo: 0001493152-26-006713), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, transaction values, financial metrics, or impacts are disclosed in the provided filing summary. No quantitative data, period-over-period comparisons, or scheduled events are mentioned.

• ·Multi-item 8-K filing indicating multiple corporate actions
• ·Filing size: 882 KB

13-02-2026

Cambridge Acquisition Corp. filed an 8-K on 2026-02-13 under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits), related to a merger/acquisition event. No deal structure, valuation, parties, strategic rationale, financial metrics, or other quantitative details are disclosed in the provided filing information. No positive or negative metrics reported.

13-02-2026

Live Oak Bancshares, Inc. filed an 8-K on February 13, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits are included. No specific details such as officer names, positions affected, appointment or resignation status, reasons, or quantitative data are disclosed.

13-02-2026

Inception Growth Acquisition Ltd filed an 8-K on February 13, 2026 (AccNo: 0001213900-26-016421, Size: 263 KB), disclosing other events under Item 8.01, likely related to a merger/acquisition. Item 9.01 includes financial statements and exhibits. No specific deal structure, financial metrics, parties involved, or quantitative data are explicitly stated.

• ·AccNo: 0001213900-26-016421
• ·Sector: NOT_DISCLOSED

13-02-2026

Huntsman Corp filed a Form 8-K on February 13, 2026, reporting entry into a new material definitive agreement under Item 1.01 while simultaneously disclosing termination of a prior material definitive agreement under Item 1.02; however, it also announced creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. Item 9.01 provides financial statements and exhibits. This multi-item filing signals significant contractual and financial changes, but no specific details, dollar values, or impacts are disclosed.

13-02-2026

Apple Hospitality REIT, Inc. filed a Form 8-K on 2026-02-13 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, or timing are provided in the filing summary. No quantitative data, performance metrics, or further governance implications are disclosed.

13-02-2026

TransDigm Group Inc filed an 8-K on February 13, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction values, financial impacts, or other quantitative details are disclosed.

13-02-2026

Data Storage Corp filed an 8-K on February 13, 2026, disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons for changes, or any quantitative metrics are disclosed.

13-02-2026

Emerson Electric Co filed an 8-K on February 13, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, strategic impacts, or financial metrics are disclosed.

13-02-2026

SAGA COMMUNICATIONS INC filed an 8-K on February 13, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer's name, title, reason for change, timing, or any quantitative metrics are disclosed.

13-02-2026

Transact Technologies Inc filed an 8-K on February 13, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, or financial impacts are disclosed.

13-02-2026

Envirotech Vehicles, Inc. filed an 8-K on February 13, 2026, reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, including transfer of listing. Item 8.01 discloses other events. No financial metrics, quantitative data, or period-over-period comparisons provided.

13-02-2026

Martin Marietta Materials Inc filed an 8-K on February 13, 2026, disclosing under Item 1.04 mine safety matters involving reporting of shutdowns and patterns of violations. No additional quantitative details, financial impacts, or operational specifics were provided in the filing summary.

13-02-2026

Cencora, Inc. filed a Form 8-K on February 13, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, under Item 7.01 Regulation FD disclosure, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This multi-item filing indicates significant corporate actions but provides no quantitative details on transaction size, financial impacts, or strategic context. No positive or negative metrics are disclosed.

13-02-2026

Werewolf Therapeutics, Inc. filed an 8-K on February 13, 2026, disclosing costs associated with exit or disposal activities under Item 2.05, officer or director changes including departures, elections, appointments, or compensatory arrangements under Item 5.02, and Regulation FD disclosure under Item 7.01. No specific details on personnel changes, reasons, costs, or financial impacts are disclosed. This combination signals potential restructuring but lacks quantification for assessment.

13-02-2026

NORTHROP GRUMMAN CORP /DE/ filed an 8-K on February 13, 2026 (AccNo: 0001628280-26-008140), disclosing an officer change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected officer, position, action (appointment or resignation), reason, effective date, or any quantitative data are disclosed.

• ·Event Type: Officer Change
• ·Source: us_sec
• ·Sector: not specified
• ·Filing Size: 190 KB

13-02-2026

QuidelOrtho Corp filed an 8-K on February 13, 2026 (AccNo: 0001193125-26-051461), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the affected officer, position, reason for change, or timing are disclosed. Sector is not specified.

• ·Filing size: 130 KB

13-02-2026

Knight-Swift Transportation Holdings Inc. filed an 8-K on February 13, 2026 (AccNo: 0001492691-26-000012), disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or financial terms are disclosed in the provided filing summary. No quantitative metrics, performance comparisons, or scheduled events mentioned.

13-02-2026

Nuvve Holding Corp. filed an 8-K on February 13, 2026, reporting under Item 1.02 the termination of a material definitive agreement, which represents a negative development. Item 9.01 discloses financial statements and exhibits. No quantitative financial impacts, transaction values, or strategic details are provided.

13-02-2026

Pebblebrook Hotel Trust filed a Form 8-K on February 13, 2026, under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing signaling a significant agreement and new financial commitment, but no specific transaction details, dollar values, financial impacts, or metrics are disclosed. No positive or negative quantitative changes are mentioned.

13-02-2026

Lithia Motors Inc filed an 8-K on February 13, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) with Item 9.01 for Financial Statements and Exhibits. No specific details on the key position affected, appointment or resignation, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other changes are mentioned.

13-02-2026

Hormel Foods Corp /DE/ filed an 8-K on February 13, 2026, disclosing an officer change under Item 5.02, covering departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included, but specific details such as names, titles, reasons for change, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.

13-02-2026

BRAINSTORM CELL THERAPEUTICS INC. filed an 8-K on February 13, 2026 (AccNo: 0001104659-26-015262), reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, accompanied by financial statements and exhibits under Item 9.01. No quantitative details such as transaction values, share counts, or financial impacts are disclosed. This multi-item filing signals a potentially significant financing or partnership event typical in biotech but lacks specifics on terms or effects.

• ·Filing Accession Number: 0001104659-26-015262
• ·File Size: 730 KB
• ·Multi-item mandatory 8-K filing

13-02-2026

Idea Acquisition Corp. filed an 8-K on 2026-02-13 disclosing entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, departures/elections/appointments of directors/officers and compensatory arrangements under Item 5.02, amendments to articles of incorporation or bylaws under Item 5.03, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on deal structure, parties, valuation, or financial metrics are provided in the filing summary. All quantitative and qualitative transaction specifics are NOT_DISCLOSED.

13-02-2026

Red Robin Gourmet Burgers Inc filed a Form 8-K on February 13, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement's nature, parties, terms, dollar value, or financial impacts are disclosed. No quantitative metrics, period-over-period comparisons, positive or negative changes, or operational data are provided in the filing summary.

13-02-2026

Peraso Inc. filed an 8-K on February 13, 2026 (AccNo: 0001213900-26-016466), disclosing an officer change under Item 5.02 covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific names, positions affected, reasons for change, or quantitative details are disclosed.

• ·File size: 189 KB

13-02-2026

SmartKem, Inc. filed a Form 8-K on February 13, 2026 (AccNo: 0001104659-26-015258), reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. This indicates the company has been notified by its exchange of non-compliance with listing requirements. No financial metrics, transaction values, or additional details such as reasons for the notice or impacts were disclosed.

13-02-2026

Iveda Solutions, Inc. filed a Form 8-K on February 13, 2026 (AccNo: 0001493152-26-006726), reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, events, dollar values, or financial impacts disclosed in the provided summary. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

13-02-2026

FG Nexus Inc. filed an 8-K on February 13, 2026, disclosing under Item 3.03 material modifications to the rights of security holders and under Item 5.03 amendments to its articles of incorporation or bylaws or change in fiscal year. Item 9.01 includes financial statements and exhibits. No financial metrics, transaction details, or directional impacts are specified.

13-02-2026

Quetta Acquisition Corp filed an 8-K on February 13, 2026 (AccNo: 0001493152-26-006730, Size: 256 KB) disclosing information under Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific names, dates, details, financial metrics, or transaction information are mentioned in the filing summary. Sector not specified, and no merger/acquisition details provided.

13-02-2026

International Tower Hill Mines Ltd filed an 8-K on February 13, 2026 (AccNo: 0001104659-26-015257), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other material data points are provided in the filing summary.

13-02-2026

United Acquisition Corp. I filed an 8-K on February 13, 2026 (AccNo: 0001493152-26-006747), disclosing unregistered sales of equity securities under Item 3.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on deal structure, parties involved, valuation, transaction terms, synergies, regulatory pathway, or shareholder impacts are provided in the filing summary. All quantitative metrics, including transaction value and share counts, are NOT_DISCLOSED.

13-02-2026

Sysco Corp filed an 8-K on 2026-02-13 reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or obligation under an off-balance sheet arrangement under Item 2.03, with financial statements and exhibits provided under Item 9.01. No quantitative details such as transaction value, financial terms, or impacts on revenue, earnings, or balance sheet are disclosed. This is a multi-item mandatory disclosure of material events.

13-02-2026

Hyperscale Data, Inc. filed an 8-K on February 13, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 a Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details, transaction terms, financial metrics, positive or negative impacts, or quantitative data are disclosed in the provided filing summary. This is a multi-item filing with no information on timing compliance relative to the event.

13-02-2026

Goldman Sachs Group Inc filed an 8-K on February 13, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for changes, or impacts are disclosed. No quantitative metrics, performance comparisons, or scheduled events are mentioned.

13-02-2026

AMERICAN STATES WATER CO filed a Form 8-K on February 13, 2026 (AccNo: 0001628280-26-008178), disclosing an officer change under Item 5.02, which pertains to departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, timing, or any named individuals are provided in the filing summary. No quantitative data, financial metrics, or further governance implications are disclosed.

13-02-2026

Longeveron Inc. filed an 8-K on 2026-02-13 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

13-02-2026

Kontoor Brands, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001760965-26-000006), disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details including the key position affected, individual names, appointment/resignation status, reasons, or any quantitative impacts are NOT_DISCLOSED.

13-02-2026

Profusa, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001213900-26-016496), reporting entry into a material definitive agreement under Item 1.01 and other events under Item 8.01. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement terms, transaction value, financial impacts, or other events are provided.

13-02-2026

Phoenix Energy One, LLC filed a Form 8-K on February 13, 2026 (AccNo: 0001193125-26-051726), reporting under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 includes Financial Statements and Exhibits. No specific terms, dollar values, strategic details, or financial impacts of the agreement are disclosed in the provided filing summary.

13-02-2026

HELIX ENERGY SOLUTIONS GROUP INC filed an 8-K on 2026-02-13 disclosing entry into a Material Definitive Agreement under Item 1.01, accompanied by Financial Statements and Exhibits under Item 9.01. No specific transaction details, dollar values, financial impacts, positive or negative metrics, or period-over-period comparisons are disclosed in the provided filing summary.

13-02-2026

CoStar Group, Inc. filed an 8-K on February 13, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals, reasons, or terms are disclosed.

13-02-2026

NexMetals Mining Corp. filed an 8-K on 2026-02-13 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Other Events in Item 8.01 and Financial Statements and Exhibits in Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or individuals involved are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

13-02-2026

FLYEXCLUSIVE INC. filed a Form 8-K on February 13, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. This represents a multi-item mandatory filing with no specific details provided on the agreement's nature, parties, terms, value, or impacts. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

• ·Sector: not specified

13-02-2026

BayFirst Financial Corp. filed an 8-K on 2026-02-13 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the individuals involved, reasons for change, timing, or impacts are disclosed.

13-02-2026

Crypto Co filed an 8-K on February 13, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits attached under Item 9.01. No specific transaction values, share counts, financial impacts, or other quantitative details are disclosed. This is a multi-item filing with no period-over-period comparisons or guidance changes mentioned.

13-02-2026

UFP Technologies Inc filed an 8-K on February 13, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 refers to financial statements and exhibits. No specific details on affected positions, individuals, reasons for changes, or financial metrics are disclosed.

13-02-2026

Timken Co filed an 8-K on February 13, 2026 (AccNo: 0000098362-26-000014) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, internal/external status, and any board composition impacts are NOT_DISCLOSED. No quantitative data, financial metrics, scheduled events, or governance implications are provided in the summary.

13-02-2026

IDEXX Laboratories Inc./DE filed an 8-K on February 13, 2026 (AccNo: 0000874716-26-000007, Size: 276 KB) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, timing, or quantitative impacts are disclosed. This is a routine governance disclosure with no financial metrics or performance data provided.

13-02-2026

Streamex Corp. filed a Form 8-K on February 13, 2026, disclosing under Item 1.02 the termination of a material definitive agreement, which signals a potentially negative development, while Item 5.02 reports departures of directors or certain officers alongside elections, appointments, and compensatory arrangements of certain officers, indicating leadership transitions. Item 8.01 covers other events and Item 9.01 includes financial statements and exhibits. This multi-item filing highlights significant corporate changes but provides no quantified financial impacts or further details.

13-02-2026

BRC Inc. filed a Form 8-K on 2026-02-13 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, including potential transfer of listing. The filing also reports Regulation FD disclosure in Item 7.01 and attaches financial statements and exhibits in Item 9.01. No quantitative financial metrics, transaction values, or specific reasons for the delisting event are disclosed.

13-02-2026

Actinium Pharmaceuticals, Inc. filed an 8-K on February 13, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, names, reasons for change, or quantitative data are disclosed. Sector information is not specified.

13-02-2026

Orchestra BioMed Holdings, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001104659-26-015315), disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, titles, reasons for changes, timing details, compensation amounts, or other quantitative metrics are disclosed. Sector information is not specified.

13-02-2026

OXBRIDGE RE HOLDINGS Ltd filed an 8-K on February 13, 2026 (AccNo: 0001493152-26-006760), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement, transaction size, parties, financial impacts, or metrics are provided in the filing summary.

13-02-2026

Delta Air Lines, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001683168-26-001033), disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or impacts were provided. Sector not specified.

13-02-2026

ATN International, Inc. filed a Form 8-K on February 13, 2026, disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, accompanied by Regulation FD disclosure under Item 7.01 and exhibits under Item 9.01. No specific details on the nature of the agreement, transaction size, financial terms, or impacts are provided in the filing summary. This multi-item filing signals potentially significant but undisclosed corporate developments.

13-02-2026

Envoy Medical, Inc. filed a Form 8-K on February 13, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, events, transaction value, financial impacts, or quantitative metrics disclosed in the provided information. No positive or negative metrics, period-over-period changes, or guidance were mentioned.

13-02-2026

Charlie's Holdings, Inc. filed an 8-K on February 13, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with exhibits under Item 9.01. No specific details on the agreement terms, transaction value, share counts, or financial impacts are disclosed. This is a multi-item mandatory filing with no quantitative metrics provided.

13-02-2026

Wellgistics Health, Inc. filed a multi-item Form 8-K on February 13, 2026 (AccNo: 0001493152-26-006815, Size: 12 MB), reporting Item 1.01 Entry into a Material Definitive Agreement, Item 3.02 Unregistered Sales of Equity Securities, Item 7.01 Regulation FD Disclosure, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. No specific details, transaction values, financial metrics, or impacts are disclosed in the provided filing summary. This informational filing lacks quantitative data for assessing positive or negative implications.

13-02-2026

Banzai International, Inc. filed a Form 8-K on 2026-02-13 disclosing entry into a Material Definitive Agreement under Item 1.01, accompanied by Financial Statements and Exhibits under Item 9.01. No specific details on the agreement, transaction terms, financial impacts, or quantitative metrics are provided in the filing summary. No positive or negative performance metrics, comparisons, or other data are mentioned.

13-02-2026

IO Biotech, Inc. filed a Form 8-K on 2026-02-13 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. This event signals potential removal from a US exchange, negatively impacting stock liquidity and accessibility for US investors. No financial metrics, quantitative impacts, or additional details such as dollar values or timelines were disclosed.

13-02-2026

Funko, Inc. filed a Form 8-K on February 13, 2026, disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 reports financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or performance metrics are disclosed.

13-02-2026

Sensei Biotherapeutics, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001193125-26-051815), disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics such as compensation amounts are disclosed. No positive or negative performance metrics, comparisons, or financial impacts are mentioned.